Lyme Disease Awareness Month.
Fiscal committee
No
Current location
Chaptered
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This resolution designates May 2026 as Lyme Disease Awareness Month in California. It highlights the significant health challenges posed by Lyme disease, emphasizing its often-misdiagnosis, potential for long-term complications, and the difficulty in obtaining accurate diagnoses. The resolution aims to raise awareness about the disease and its impact on Californians, particularly considering its prevalence in the state and the potential for co-infections.
Key provisions
- Proclaims May 2026 as Lyme Disease Awareness Month in California.
- Recognizes Lyme disease as a complex illness with potential for long-term health problems.
- Acknowledges the challenges in diagnosing Lyme disease due to the lack of reliable testing.
- Highlights the prevalence of Lyme disease in California, particularly in coastal regions and certain counties.
- Mentions the potential for co-infections with diseases like babesiosis, anaplasmosis, and ehrlichiosis.
- Notes the presence of five distinct borrelia species in California, making it a focus region for these bacteria.
- States that ticks are active year-round, especially in wet conditions.
- References the western blacklegged tick (Ixodes pacificus) as the primary vector for Lyme disease in California.
Who is affected
- Californians
- People who spend time outdoors in wooded or grassy areas
- Children
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
66 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours